Filed 2mo ago· Mar 24, 2026
39 days to disclose
Angus S., Jr. King
ISenateMaine
↓sold
Eli Lilly
LLY
$1K-$15K
−5.8% vs S&P 500
Trade dateFeb 13, 2026
Stock trades that members of the U.S. House and Senate disclose, by law, after they buy or sell. Pulled straight from the official government websites — typically posted within hours of being filed.






















| Filed | Politician | Type | Stock | Trade date | Smart move? | Size |
|---|---|---|---|---|---|---|
Mar 24, 2026 2mo ago | ![]() Angus S., Jr. King ISenateMaine | ↓sold | Eli Lilly LLY | Feb 13, 2026 39 days to disclose | Flat·+0.0% −5.8% vs S&P 500 | $1K-$15K midpoint $8K |
Jan 26, 2026 4mo ago | ![]() Angus S., Jr. King ISenateMaine | ↑bought | Eli Lilly LLY | Dec 29, 2025 28 days to disclose | Bad buy·−$67-0.8% +3.8% vs S&P 500 | $1K-$15K midpoint $8K |
Jan 16, 2026 4mo ago | ![]() Markwayne Mullin RSenateOklahoma | ↑bought | Eli Lilly LLY | Dec 29, 2025 18 days to disclose | Bad buy·−$701-2.2% +2.5% vs S&P 500 | $15K-$50K midpoint $32.5K |
Dec 8, 2025 5mo ago | ![]() John Boozman RSenateArkansas | ↓sold | Eli Lilly LLY | Nov 21, 2025 17 days to disclose | Flat·+0.0% −3.9% vs S&P 500 | $1K-$15K midpoint $8K |
Nov 4, 2025 7mo ago | ![]() Shelley Moore Capito RSenateWest Virginia | ↑bought | Eli Lilly LLY ⚑ Pharmaceutical · Commerce, Science, and Transportation | Oct 24, 2025 11 days to disclose | Good buy·+$2.2K+27.9% +26.2% vs S&P 500 | $1K-$15K midpoint $8K |
Sep 12, 2025 8mo ago | ![]() John Boozman RSenateArkansas | ↑bought | Eli Lilly LLY | Aug 22, 2025 21 days to disclose | Good buy·+$3.9K+48.3% +40.8% vs S&P 500 | $1K-$15K midpoint $8K |
Sep 12, 2025 8mo ago | ![]() John Boozman RSenateArkansas | ↑bought | Eli Lilly LLY | Aug 11, 2025 32 days to disclose | Good buy·+$5.3K+66.2% +52.2% vs S&P 500 | $1K-$15K midpoint $8K |
Aug 12, 2025 9mo ago | ![]() Markwayne Mullin RSenateOklahoma | ↑bought | Eli Lilly LLY | Dec 11, 2024 244 days to disclose · 199 past 45-day window | Good buy·+$24.4K+32.6% +28.1% vs S&P 500 | $50K-$100K midpoint $75K |
May 15, 2025 1.1y ago | ![]() Tommy Tuberville RSenateAlabama | ↓sold | Eli Lilly LLY ⚑ Pharmaceutical · Health, Education, Labor, and Pensions | Apr 15, 2025 30 days to disclose | Flat·+0.0% +7.9% vs S&P 500 | $15K-$50K midpoint $32.5K |
Mar 22, 2025 1.2y ago | ![]() Ashley Moody RSenateFlorida | ↑bought | OTH LLY Stock | Mar 6, 2025 16 days to disclose | price pending | $100K-$250K midpoint $175K |
Feb 21, 2025 1.3y ago | ![]() Ron Wyden DSenateOregon | ↓sold | Eli Lilly LLY ⚑ Pharmaceutical · Finance | Feb 10, 2025 11 days to disclose | Flat·+0.0% +1.5% vs S&P 500 | $50K-$100K midpoint $75K |
Feb 21, 2025 1.3y ago | ![]() Ron Wyden DSenateOregon | ↑bought | Eli Lilly LLY ⚑ Pharmaceutical · Finance | Jan 22, 2025 30 days to disclose | Good buy·+$31.4K+41.9% +37.4% vs S&P 500 | $50K-$100K midpoint $75K |
Nov 7, 2024 1.6y ago | ![]() Sheldon Whitehouse DSenateRhode Island | ↑bought | Eli Lilly LLY ⚑ Pharmaceutical · Commerce, Science, and Transportation | Oct 30, 2024 8 days to disclose | Good buy·+$11.1K+34.1% +33.9% vs S&P 500 | $15K-$50K midpoint $32.5K |
May 15, 2024 2.1y ago | ![]() Tommy Tuberville RSenateAlabama | ↓sold | Eli Lilly LLY ⚑ Pharmaceutical · Health, Education, Labor, and Pensions | Apr 3, 2024 42 days to disclose | Missed gain·−$4.5K-13.9% +23.5% vs S&P 500 | $15K-$50K midpoint $32.5K |
Feb 14, 2024 2.3y ago | ![]() Tommy Tuberville RSenateAlabama | ↓sold | Eli Lilly LLY ⚑ Pharmaceutical · Health, Education, Labor, and Pensions | Jan 3, 2024 42 days to disclose | Flat·+0.0% +7.2% vs S&P 500 | $15K-$50K midpoint $32.5K |
Jan 18, 2024 2.4y ago | ![]() Sheldon Whitehouse DSenateRhode Island | ↑bought | Eli Lilly LLY ⚑ Pharmaceutical · Commerce, Science, and Transportation | Dec 14, 2023 35 days to disclose | Good buy·+$4.3K+54.1% +2.8% vs S&P 500 | $1K-$15K midpoint $8K |
Nov 1, 2023 2.6y ago | ![]() Markwayne Mullin RSenateOklahoma | ↑bought | Eli Lilly LLY | Oct 3, 2023 29 days to disclose | Good buy·+$5.5K+68.3% −1.0% vs S&P 500 | $1K-$15K midpoint $8K |
Oct 17, 2023 2.6y ago | ![]() Sheldon Whitehouse DSenateRhode Island | ↑bought | Eli Lilly LLY ⚑ Pharmaceutical · Commerce, Science, and Transportation | Sep 20, 2023 27 days to disclose | Good buy·+$17.9K+55.2% −7.6% vs S&P 500 | $15K-$50K midpoint $32.5K |
Oct 13, 2023 2.6y ago | ![]() Tommy Tuberville RSenateAlabama | ↓sold | Eli Lilly LLY ⚑ Pharmaceutical · Health, Education, Labor, and Pensions | Sep 8, 2023 35 days to disclose | Flat·+0.0% +12.5% vs S&P 500 | $1K-$15K midpoint $8K |
Oct 12, 2023 2.6y ago | ![]() Markwayne Mullin RSenateOklahoma | ↑bought | Eli Lilly LLY | Sep 13, 2023 29 days to disclose | Good buy·+$15.5K+47.6% −12.3% vs S&P 500 | $15K-$50K midpoint $32.5K |
Oct 4, 2023 2.7y ago | ![]() John R. Curtis RSenateUtah | ↑bought | Eli Lilly LLY ⚑ Pharmaceutical · Commerce, Science, and Transportation | Sep 13, 2023 21 days to disclose | Good buy·+$3.8K+47.6% −12.3% vs S&P 500 | $1K-$15K midpoint $8K |
Feb 14, 2022 4.3y ago | ![]() Tommy Tuberville RSenateAlabama | ↓sold | Eli Lilly LLY ⚑ Pharmaceutical · Health, Education, Labor, and Pensions | Jan 14, 2022 31 days to disclose | Missed gain·−$85.2K-262.1% −208.5% vs S&P 500 | $15K-$50K midpoint $32.5K |
May 2, 2021 5.1y ago | DJ David A Perdue , Jr —Senate | ↓sold | Eli Lilly LLY | Apr 16, 2020 381 days to disclose · 336 past 45-day window | price pending | $1K-$15K midpoint $8K |